Label: LAPATINIB powder

  • NDC Code(s): 86032-017-01
  • Packager: Evereen Shanghai Biotechnology Ltd.
  • Category: BULK INGREDIENT - ANIMAL DRUG
  • DEA Schedule: None
  • Marketing Status: Bulk Ingredient For Animal Drug Compounding

Drug Label Information

Updated November 9, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • Lapatinib

    image description

  • INGREDIENTS AND APPEARANCE
    LAPATINIB 
    lapatinib powder
    Product Information
    Product TypeItem Code (Source)NDC:86032-017
    Route of AdministrationNOT APPLICABLE
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LAPATINIB (UNII: 0VUA21238F) (LAPATINIB - UNII:0VUA21238F) LAPATINIB1 g  in 1 g
    Product Characteristics
    ColoryellowScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:86032-017-011000 g in 1 BAG
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    bulk ingredient for animal drug compounding11/09/2022
    Labeler - Evereen Shanghai Biotechnology Ltd. (711547777)
    Establishment
    NameAddressID/FEIBusiness Operations
    Evereen Shanghai Biotechnology Ltd.711547777relabel
    Establishment
    NameAddressID/FEIBusiness Operations
    Shandong Boyuan Pharmaceutical Co., Ltd.421325415api manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!